Ocera Therapeutics, Inc. Contracts & Agreements

Agreement and Plan of Merger, dated November 1, 2017 by and among Ocera Therapeutics, Inc., MAK LLC, MEH Acquisition Co., and for limited purposes, Mallinckrodt plc (Filed With SEC on November 2, 2017)

OCERA THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY As Amended and Restated March 29, 2017 (Filed With SEC on May 9, 2017)

AMENDMENT TO AMENDED AND RESTATED AGREEMENT OF EMPLOYMENT (Filed With SEC on March 31, 2017)

THIRD AMENDMENT TO LEASE AGREEMENT (Filed With SEC on August 4, 2016)

OCERA THERAPEUTICS, INC. FOURTH AMENDED AND RESTATED 2011 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on June 15, 2016)

AMENDED AND RESTATED AGREEMENT OF EMPLOYMENT (Filed With SEC on May 3, 2016)

OCERA THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY As Amended and Restated March 31, 2016 (Filed With SEC on May 3, 2016)

SECOND AMENDED AND RESTATED LICENSE AGREEMENT (Filed With SEC on March 11, 2016)

OCERA THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY As Amended and Restated April 23, 2015 (Filed With SEC on March 11, 2016)

AGREEMENT OF EMPLOYMENT (Filed With SEC on January 8, 2016)

AMENDED AND RESTATED AGREEMENT OF EMPLOYMENT (Filed With SEC on January 8, 2016)

SECOND AMENDMENT TO LEASE AGREEMENT (Filed With SEC on August 10, 2015)

OCERA THERAPEUTICS, INC. $25,000,000 SALES AGREEMENT (Filed With SEC on August 10, 2015)

WARRANT TO PURCHASE STOCK (Filed With SEC on August 4, 2015)

WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on August 4, 2015)

LOAN AND SECURITY AGREEMENT (Filed With SEC on August 4, 2015)

OCERA THERAPEUTICS, INC. THIRD AMENDED AND RESTATED 2011 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on June 22, 2015)

FIRST AMENDMENT TO LEASE AGREEMENT (Filed With SEC on November 13, 2014)

Ocera Therapeutics, Inc. (Filed With SEC on September 22, 2014)

OCERA THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY As Amended and Restated (Filed With SEC on September 22, 2014)

CONSULTING AGREEMENT (Filed With SEC on August 13, 2014)

Ocera Therapeutics, Inc. (Filed With SEC on August 11, 2014)

4,200,000 Shares OCERA THERAPEUTICS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on July 10, 2014)

TECHNOLOGY TRANSFER AND LICENSE AGREEMENT BY AND BETWEEN GENENTECH, INC., F. HOFFMANN-LA ROCHE LTD AND OCERA THERAPEUTICS, INC. (Filed With SEC on May 30, 2014)

AGREEMENT OF EMPLOYMENT (Filed With SEC on May 2, 2014)

TECHNOLOGY TRANSFER AND LICENSE AGREEMENT BY AND BETWEEN GENENTECH, INC., F. HOFFMANN-LA ROCHE LTD AND OCERA THERAPEUTICS, INC. (Filed With SEC on April 25, 2014)

TECHNOLOGY TRANSFER AND LICENSE AGREEMENT BY AND BETWEEN GENENTECH, INC., F. HOFFMANN-LA ROCHE LTD AND OCERA THERAPEUTICS, INC. (Filed With SEC on February 24, 2014)

AGREEMENT OF EMPLOYMENT (Filed With SEC on December 24, 2013)

OCERA THERAPEUTICS, INC. SECOND AMENDED AND RESTATED 2011 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on December 24, 2013)

OCERA THERAPEUTICS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on November 6, 2013)

RESTATED LICENSE AGREEMENT (Filed With SEC on September 27, 2013)

CONFIDENTIAL TREATMENT HAS BEEN REQUESTED. (Filed With SEC on September 27, 2013)

COMMERCIAL MANUFACTURE AND SUPPLY AGREEMENT (Filed With SEC on September 27, 2013)

CLINICAL MANUFACTURE AND SUPPLY AGREEMENT (Filed With SEC on September 27, 2013)

The Schedule Varied Amended and Restated Agreement (Filed With SEC on September 27, 2013)

EXHIBIT A RELEASE AND WAIVER OF CLAIMS TO BE SIGNED FOLLOWING TERMINATION WITHOUT CAUSE (Filed With SEC on September 5, 2013)

OCERA THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on September 5, 2013)

OCERA THERAPEUTICS, INC. COMMON STOCK PURCHASE WARRANT (Filed With SEC on August 14, 2013)

OCERA THERAPEUTICS, INC. INDEMNIFICATION AGREEMENT (Filed With SEC on August 14, 2013)

Ocera TH ERAP EUTICS (Filed With SEC on August 14, 2013)

Ocera Therapeutics, Inc. 12651 High Bluff Drive Suite 230 San Diego, CA 92130 June 7, 2012 (Filed With SEC on August 14, 2013)

OCERA THERAPEUTICS, INC. 2005 STOCK PLAN (Filed With SEC on August 14, 2013)

OCERA THERAPEUTICS, INC. 2005 STOCK PLAN NOTICE OF STOCK OPTION GRANT (Filed With SEC on August 14, 2013)

AGREEMENT AND PLAN OF MERGER AND REORGANIZATION among: TRANZYME, INC., a Delaware corporation; TERRAPIN ACQUISITION, INC., a Delaware corporation; and OCERA THERAPEUTICS, INC., a... (Filed With SEC on April 29, 2013)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on April 29, 2013)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on April 29, 2013)

SEVERANCE AGREEMENT (Filed With SEC on February 12, 2013)

RETENTION AND CHANGE IN CONTROL AGREEMENT (Filed With SEC on February 12, 2013)

TRANZYME, INC. 2,597,402 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on September 13, 2012)

WARRANT TO PURCHASE STOCK (Filed With SEC on February 1, 2012)

TRANZYME, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on November 10, 2011)

CHANGE IN CONTROL AGREEMENT (Filed With SEC on November 10, 2011)

Tranzyme, Inc. [ ]Shares Common Stock ($0.00001 par value) Underwriting Agreement (Filed With SEC on March 8, 2011)

TRANZYME, INC. 2011 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on March 8, 2011)

TRANZYME, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on March 8, 2011)

TRANZYME, INC. SENIOR EXECUTIVE INCENTIVE BONUS PLAN (Filed With SEC on March 8, 2011)

AMENDED AND RESTATED AGREEMENT OF EMPLOYMENT (Filed With SEC on March 8, 2011)

TRANZYME, INC. INDEMNIFICATION AGREEMENT (Filed With SEC on March 8, 2011)

HQ GlobalWorkplaces Service Agreement (Filed With SEC on December 23, 2010)

LICENSE AGREEMENT (Filed With SEC on November 19, 2010)

HQ GlobalWorkplaces Service Agreement (Filed With SEC on November 19, 2010)

Category

Industry

Companies

Contracts

Ocera Therapeutics, Inc. Contracts & Agreements